Resource Guide: FDA warning Tysabri Progressive Multifocal Leukoencephalopathy

Below is a working bibliography of trusted health, pharmacovigilance, and legal-analysis sources, compiled for open research.

Recommended deep-dive

FDA warning Tysabri Progressive Multifocal Leukoencephalopathy: A Detailed Overview

A focused review of background, context, and source material on this subject.

ClinicalTrials.gov

Reference: ClinicalTrials.gov

Authoritative source for clinical, regulatory, and public-health background reading.

World Health Organization (WHO)

Reference: World Health Organization (WHO)

Authoritative source for clinical, regulatory, and public-health background reading.